Ngo D, Tinajero J, Li S, Palmer J, et al. Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib. Leuk Lymphoma 2024 Jan 2:1-6. doi: 10.1080/10428194.2023.2292473.
PMID: 38164785